CSIMarket
 


Alpine Immune Sciences Inc   (ALPN)
Other Ticker:  
 
 

ALPN's Revenue Growth by Quarter and Year

Alpine Immune Sciences Inc 's Revenue results by quarter and year




ALPN Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 4.42 5.63 0.88
III Quarter September 8.37 8.52 1.92 0.29
II Quarter June 5.29 7.24 0.69 0.57
I Quarter March 13.63 3.27 1.09 0.00
FY   27.29 23.45 9.33 1.74



ALPN Revenue third quarter 2022 Y/Y Growth Comment
Alpine Immune Sciences Inc reported decrease in Revenue in the third quarter 2022 by -1.8% to $ 8.37 millions, from the same quarter in 2021.
The decrease in the third quarter 2022 Alpine Immune Sciences Inc 's Revenue compares unfavorably to the Company's average Revenue rise of 31.29%.

Looking into third quarter 2022 results within Major Pharmaceutical Preparations industry 131 other companies have achieved higher Revenue growth. While Alpine Immune Sciences Inc ' s Revenue decline of -1.8% ranks overall at the positon no. 2434 in the third quarter 2022.




ALPN Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -21.49 % 539.77 % -
III Quarter September -1.8 % 343.75 % 562.07 % -
II Quarter June -26.93 % 949.28 % 21.05 % 46.15 %
I Quarter March 316.82 % 200 % - -
FY   - 151.34 % 436.21 % 145.07 %

Financial Statements
Alpine Immune Sciences Inc 's third quarter 2022 Revenue $ 8.37 millions ALPN's Income Statement
Alpine Immune Sciences Inc 's third quarter 2021 Revenue $ 8.52 millions Quarterly ALPN's Income Statement
New: More ALPN's historic Revenue Growth >>


ALPN Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -48.12 % 193.23 % 203.45 %
III Quarter September 58.17 % 17.68 % 178.26 % -49.12 %
II Quarter June -61.19 % 121.41 % -36.7 % -
I Quarter March 208.37 % -41.92 % 23.86 % -
FY (Year on Year)   - 151.34 % 436.21 % 145.07 %




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #132
Healthcare Sector #373
Overall #2434

Revenue Y/Y Growth Statistics
High Average Low
103.51 % 31.29 % -5.77 %
(Dec 31 2020)   (Jun 30 2022)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #132
Healthcare Sector #373
Overall #2434
Revenue Y/Y Growth Statistics
High Average Low
103.51 % 31.29 % -5.77 %
(Dec 31 2020)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Alpine Immune Sciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
208.63 % 46.28 % -100 %
(Mar 31 2022)  


ALPN's III. Quarter Q/Q Revenue Comment
Alpine Immune Sciences Inc achieved in the III. Quarter 2022 above company average sequential Revenue jump of 58.17%, to $ 8.37 millions, from $5.29 millions in the second quarter.
Alpine Immune Sciences Inc is going from strength to strength, with reporting above average gain, but also improving rate, Alexandra Freitas, market advisor added.

Within Major Pharmaceutical Preparations industry 41 other companies have achieved higher Revenue quarter on quarter growth. While Alpine Immune Sciences Inc 's Revenue growth quarter on quarter, overall rank is 222.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #42
Healthcare Sector #71
Overall #222
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #42
Healthcare Sector #71
Overall #222
Revenue Q/Q Growth Statistics
High Average Low
208.63 % 46.28 % -100 %
(Mar 31 2022)  


ALPN's III. Quarter Q/Q Revenue Comment
Alpine Immune Sciences Inc achieved in the III. Quarter 2022 above company average sequential Revenue jump of 58.17%, to $ 8.37 millions, from $5.29 millions in the second quarter.
Alpine Immune Sciences Inc is going from strength to strength, not just reporting above average increase, and also improving speed.

Within Major Pharmaceutical Preparations industry 41 other companies have achieved higher Revenue quarter on quarter growth. While Alpine Immune Sciences Inc 's Revenue growth quarter on quarter, overall rank is 222.


Alpine Immune Sciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 31.70 $ 31.85 $ 33.81 $ 23.44 $ 24.66
Y / Y Revenue Growth (TTM) 28.57 % 76.3 % 193.68 % 151.13 % 437.58 %
Year on Year Revenue Growth Overall Ranking # 832 # 354 # 176 # 108 # 48
Seqeuential Revenue Change (TTM) -0.47 % -5.77 % 44.2 % -4.93 % 36.49 %
Seq. Revenue Growth (TTM) Overall Ranking # 2434 # 3251 # 91 # 2679 # 98




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Alpine Immune Sciences Inc 's cumulative twelve months Revenue were $ 32 millions, company would post below average annual Revenue growth of 36.49% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Alpine Immune Sciences Inc 's Revenue growth from the 5.29% growth in Jun 30 2022.

In the Healthcare sector 165 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 354 to 832.

Revenue TTM Q/Q Growth Statistics
High Average Low
103.51 %
31.29 %
-5.77 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 132
Healthcare Sector # 166
Overall # 832

Revenue TTM Y/Y Growth Statistics
High Average Low
512.03 %
243.7 %
28.57 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 132
Sector # 373
S&P 500 # 2434
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Alpine Immune Sciences Inc 's cumulative twelve months Revenue were $ 32 millions, company would post below average annual Revenue growth of 28.57% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Alpine Immune Sciences Inc 's Revenue growth from the 5.29% growth in Jun 30 2022.

In the Healthcare sector 165 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 354 to 832.

Revenue TTM Q/Q Growth Statistics
High Average Low
103.51 %
31.29 %
-5.77 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 132
Healthcare Sector # 166
Overall # 832

Revenue TTM Y/Y Growth Statistics
High Average Low
512.03 %
243.7 %
28.57 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 132
Sector # 373
S&P 500 # 2434




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ALPN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ALPN's Competitors
Revenue Growth for Alpine Immune Sciences Inc 's Suppliers
Revenue Growth for ALPN's Customers

You may also want to know
ALPN's Annual Growth Rates ALPN's Profitability Ratios ALPN's Asset Turnover Ratio ALPN's Dividend Growth
ALPN's Roe ALPN's Valuation Ratios ALPN's Financial Strength Ratios ALPN's Dividend Payout Ratio
ALPN's Roa ALPN's Inventory Turnover Ratio ALPN's Growth Rates ALPN's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Owens and Minor Inc -0.19%$ -0.191 millions
National Research Corporation-0.20%$ -0.201 millions
Livanova Plc-0.24%$ -0.241 millions
Healthcare Services Group Inc -0.27%$ -0.265 millions
Catalent Inc -0.29%$ -0.293 millions
Asensus Surgical Inc -0.31%$ -0.311 millions
Liquidia Corporation-0.43%$ -0.429 millions
Integra Lifesciences Holdings Corp-0.43%$ -0.432 millions
Pediatrix Medical Group Inc -0.62%$ -0.615 millions
China Pharma Holdings Inc -0.64%$ -0.642 millions
Acadia Pharmaceuticals Inc -0.68%$ -0.682 millions
Syneos Health Inc -0.89%$ -0.891 millions
Innovage Holding Corp -1.07%$ -1.070 millions
Procyon Corp-1.20%$ -1.200 millions
Precipio inc -1.38%$ -1.380 millions
Ati Physical Therapy Inc -1.40%$ -1.397 millions
Ocular Therapeutix Inc -1.55%$ -1.547 millions
Alpine Immune Sciences Inc -1.75%$ -1.750 millions
Surgalign Holdings Inc -1.79%$ -1.786 millions
Tenet Healthcare Corp-1.90%$ -1.900 millions
Teleflex Incorporated-1.92%$ -1.923 millions
Novocure Limited-1.95%$ -1.952 millions
Dynatronics Corporation-2.01%$ -2.014 millions
Royalty Pharma Plc-2.10%$ -2.101 millions
National Healthcare Corp-2.13%$ -2.130 millions
Fonar Corporation-2.27%$ -2.271 millions
Psychemedics Corp-2.35%$ -2.353 millions
Escalon Medical Corp -2.63%$ -2.626 millions
Lifevantage Corp-2.72%$ -2.724 millions
West Pharmaceutical Services Inc -2.77%$ -2.774 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

USAQ's Profile

Stock Price

USAQ's Financials

Business Description

Fundamentals

Charts & Quotes

USAQ's News

Suppliers

USAQ's Competitors

Customers & Markets

Economic Indicators

USAQ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071